Mesothelial cell transplantation in myocardial infarction

International Journal of Artificial Organs

Volumn 30, Issue 6, 2007, Pages 541-549

  Elmadbouh, I ^a,b   Michel, J B ^a   Chachques, Juan Carlos ^b  

^a BICHAT HOSPITAL   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Angiogenesis; Cell therapy; Cells; Gene therapy; Myocardial infarction; Myocardium regeneration

Indexed keywords

CARDIOLOGY; CELL ENGINEERING; CYTOLOGY; ENDOTHELIAL CELLS; REPAIR; STEM CELLS; TISSUE; TISSUE REGENERATION;

ANGIOGENESIS; CELL THERAPY; CELL TRANSPLANTATION; CELL-BE; CELL/B.E; CELL/BE; GENETICALLY MODIFIED; MESOTHELIAL CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM REGENERATION;

GENE THERAPY;

ADENOVIRUS VECTOR; ALKALINE PHOSPHATASE; BETA GALACTOSIDASE; CYTOKINE; ERYTHROPOIETIN; GROWTH FACTOR; PLASMID VECTOR; RETROVIRUS VECTOR; THYMIDINE KINASE;

ANGIOGENESIS; BLOOD VESSEL; CELL BASED GENE THERAPY; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL STRUCTURE; CELL TRANSPLANTATION; CORONARY ARTERY; CYTOKINE RELEASE; DNA MODIFICATION; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; EPICARDIUM; EXCISION; EXTRACELLULAR MATRIX; GENE TARGETING; HEALING; HEART FUNCTION; HEART INFARCTION; HEART INJURY; HUMAN; IN VITRO STUDY; LAVAGE; MESODERM; MESOTHELIUM CELL; NONHUMAN; PERITONEAL FLUID; PRECURSOR; REVIEW; SCAR; STEM CELL; TISSUE ENGINEERING; TISSUE INJURY; TISSUE REPAIR;

EID: 34547857797     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880703000612     Document Type: Review

References (76)

1. Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res 1998; 83: 15-26.
2. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001; 344: 1750-7.
3. Quaini F, Urbanek K, Beltrami AP, et al. Chimerism of the transplanted heart. N Engl J Med 2002; 346: 5-15.
4. Laflamme MA, Myerson D, Saffitz JE, Murry CE. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 2002; 90: 634-40.
5. Deb A, Wang S, Skelding KA, Miller D, Simper D, Caplice NM. Bone marrow-derived cardiomyocytes are present in adult human heart: A study of gender-mismatched bone marrow transplantation patients. Circulation 2003; 107: 1247-9.
6. Wessels A, Perez-Pomares JM. The epicardium and epicardially derived cells (EPDCs) as cardiac stem cells. Anat Rec 2004; 276: 43-57.
7. Chachques JC, Acar C, Herreros J, et al. Cellular cardiomyoplasty: Clinical application. Ann Thorac Surg 2004; 77: 1121-30.
8. Chachques JC, Salanson-Lajos C, Lajos P, Shafy A, Alshamry A, Carpentier A. Cellular cardiomyoplasty for myocardial regeneration. Asian Cardiovasc Thorac Ann 2005; 13: 287-96.
9. Kim EJ, Li RK, Weisel RD, et al. Angiogenesis by endothelial cell transplantation. J Thorac Cardiovasc Surg 2001; 122: 963-71.
10. Davani S, Marandin A, Mersin N, et al. Mesenchymal progenitor cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a rat cellular cardiomyoplasty model. Circulation 2003; 108 Suppl 1: II253-8.
11. Elmadbouh I, Chen Y, Louedec L, et al. Mesothelial cell transplantation in the infarct scar induces neovascularization and improves heart function. Cardiovasc Res 2005; 68: 307-17.
12. Lee MS, Lill M, Makkar RR. Stem cell transplantation in myocardial infarction. Rev Cardiovasc Med 2004; 5: 82-98.
13. Mutsaers SE. Mesothelial cells: Their structure, function and role in serosal repair. Respirology 2002; 7: 171-91.
14. Asano T, Takazawa R, Yamato M, Kageyama Y, Kihara K, Okano T. Novel and simple method for isolating autologous mesothelial cells from the tunica vaginalis. BJU Int 2005; 96: 1409-13.
15. Ueda J, Iwata T, Takahashi M, Hoshii Y, Ishihara T. Comparative immunochemical study of lectin-binding sites and cytoskeletal filaments in static and reactive mesothelium and adenocarcinoma. Pathol Int 2001; 51: 431-9.
16. Kluge T, Hovig T. The ultrastructure of human and rat pericardium. II. Intercellular spaces and junctions. Acta Pathol Microbiol Scand 1967; 71: 547-63.
17. Foley-Comer AJ, Herrick SE, Al-Mishlab T, Prele CM, Laurent GJ, Mutsaers SE. Evidence for incorporation of free-floating mesothelial cells as a mechanism of serosal healing. J Cell Sci 2002; 115: 1383-9.
18. Nagy JA, Shockley TR, Masse EM, Harvey VS, Jackman RW. Mesothelial cell-mediated gene therapy: Feasibility of an ex vivo strategy. Gene Ther 1995; 2: 393-401.
19. Hernando A, Garcia-Honduvilla N, Bellon JM, Bujan J, Navlet J. Coatings for vascular prostheses: Mesothelial cells express specific markers for muscle cells and have biological activity similar to that of endothelial cells. Eur J Vasc Surg 1994; 8: 531-6.
20. Di Paolo N, Sacchi G, Vanni L, et al. Autologous peritoneal mesothelial cell implant in rabbits and penitoneal dialysis patients. Nephron 1991; 57: 323-31.
21. Mutsaers SE, Whitaker D, Papadimitriou JM. Mesothelial regeneration is not dependent on subserosal cells. J Pathol 2000; 190: 86-92.
22. Davila RM, Crouch EC. Role of mesothelial and submesothelial stromal cells in matrix remodeling following pleural injury. Am J Pathol 1993; 142: 547-55.
23. Sun X, Gulyas M, Hjerpe A. Mesothelial differentiation as reflected by differential gene expression. Am J Respir Cell Mol Biol 2004; 30: 510-8.
24. Nevado J, Vallejo S, El-Assar M, Peiro C, Sanchez-Ferrer CF. Rodriguez-Manas L. Changes in the human peritoneal mesothelial cells during aging. Kidney Int 2006; 69: 313-22.
25. Munoz-Chapuli R, Gonzalez-Iriarte M, Carmona R, Atencia G, Macias D, Perez-Pomares JM. Cellular precursors of the coronary arteries. Tex Heart Inst J 2002; 29: 243-9.
26. Wilm B, Ipenberg A, Hastie ND, Burch JB, Bader DM. The serosal mesothelium is a major source of smooth muscle cells of the gut vasculature. Development 2005; 132: 5317-28.
27. Tiwari A, Kidane A, Punshon G, Hamilton G, Seifalian AM. Extraction of cells for single-stage seeding of vascular-bypass grafts. Biotechnol Appl Biochem 2003; 38: 35-41.
28. Herrick SE, Mutsaers SE. Mesothelial progenitor cells and their potential in tissue engineering. Int J Biochem Cell Biol 2004; 36: 621-42.
29. Yang AH, Chen JY, Lin JK. Myofibroblastic conversion of mesothelial cells. Kidney Int 2003; 63: 1530-9.
30. Yanez-Mo M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 2003; 348: 403-13.
31. Mutsaers SE. The mesothelial cell. Int J Biochem Cell Biol 2004; 36: 9-16.
32. Hekking LH, Zweers MM, Keuning ED, Driesprong BA, de Waart DR, Beelen RH, van den Born J. Apparent successful mesothelial cell transplantation hampered by peritoneal activation. Kidney Int 2005; 68: 2362-7.
33. Bertram P, Tietze L, Hoopmann M, Treutner KH, Mittermayer C, Schumpelick V. Intraperitoneal transplantation of isologous mesothelial cells for prevention of adhesions. Eur J Surg 1999; 165: 705-9.
34. Hekking LH, Harvey VS, Havenith CE, et al. Mesothelial cell transplantation in models of acute inflammation and chronic peritoneal dialysis. Perit Dial Int 2003; 23: 323-30.
35. Einbinder T, Sufaro Y, Yusim I, et al. Correction of anemia in uremic mice by genetically modified peritoneal mesothelial cells. Kidney Int 2003; 63: 2103-12.
36. Lucas PA, Warejcka DJ, Zhang LM, Newman WH, Young HE. Effect of rat mesenchymal stem cells on development of abdominal adhesions after surgery. J Surg Res 1996; 62: 229-32.
37. Verhagen HJ, Blankensteijn JD, de Groot PG, et al. In vivo experiments with mesothelial cell seeded ePTFE vascular grafts. Eur J Vasc Endovasc Surg 1998; 15: 489-96.
38. Louagie Y, Legrand-Monsieur A, Remacle C, Maldague P, Lambotte L, Ponlot R. Morphology and fibrinolytic activity of canine autogenous mesothelium used as venous substitute. Res Exp Med (Berl) 1986; 186: 239-47.
39. Pittilo RM, Bull HA, Blow CM, Woolf N, Machin SJ. Mesothelial cell seeding of Dacron arterial prostheses. Lancet 1985; 1: 347-8.
40. Bearn PE, Seddon AM, McCollum CN, Marston A. Mesothelial seeding of knitted Dacron. Br J Surg 1993; 80: 587-91.
41. Campbell JH, Efendy JL, Campbell GR. Novel vascular graft grown within recipient's own peritoneal cavity. Circ Res 1999; 85: 1173-8.
42. Moldovan NI, Havemann K. Transdifferentiation, a potential mechanism for covering vascular grafts grown within recipient's peritoneal cavity with endothelial-like cells. Circ Res 2002; 91: e1.
43. Goldsmith HS, Griffith AL, Catsimpoolas N. Increased vascular perfusion after administration of an omental lipid fraction. Surg Gynecol Obstet 1986; 162: 579-83.
44. Chamorro M, Carceller F, Llanos C, Rodriguez-Alvarino A, Colmenero C, Burgueno M. The effect of omental wrapping on nerve graft regeneration. Br J Plast Surg 1993; 46: 426-9.
45. Henry E, Courbier R, Monties JR, Torresani J, Figarella J, Garabedian B. [Surgical treatment of coronary insufficiency by epiplooplasty. Experimental study]. Ann Chir Thorac Cardiovasc 1964; 148: 228-38.
46. Goldsmith HS, Steward E, Duckett S. Early application of pedicled omentum to the acutely traumatised spinal cord. Paraplegia 1985; 23: 100-12.
47. Castaneda F, Kinne RK. Omental graft improves functional recovery of transected peripheral nerve. Muscle Nerve 2002; 26: 527-32.
48. Chachques JC, Shafy A, Duarte F, et al. From dynamic to cellular cardiomyoplasty. J Card Surg 2002; 17: 194-200.
49. Rajnoch C, Chachques JC, Berrebi A, Bruneval P, Benoit MO, Carpentier A. Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg 2001; 121: 871-8.
50. Chachques JC, Herreros J, Trainini J, et al. Autologous human serum for cell culture avoids the implantation of cardioverter-defibrillators in cellular cardiomyoplasty. Int J Cardiol 2004; 95 (suppl 1): S29-33.
51. Chachques JC, Duarte F, Cattadori B, et al. Angiogenic growth factors and/or cellular therapy for myocardial regeneration: A comparative study. J Thorac Cardiovasc Surg 2004; 128: 245-53.
52. Hoff CM. Ex vivo and in vivo gene transfer to the peritoneal membrane in a rat model. Nephrol Dial Transplant 2001; 16: 666-8.
53. Ohan J, Gilbert MA, Leseche G, Panis Y, Midoux P, Drouet L. Nonviral gene transfer into primary cultures of human and porcine mesothelial cells. In Vitro Cell Dev Biol Anim 2001; 37: 402-7.
54. Elmadbouh I, Rossignol P, Meilhac O, et al. Optimization of in vitro vascular cell transfection with non-viral vectors for in vivo applications. J Gene Med 2004; 6: 1112-24.
55. Devin CJ, Lee YC, Light RW, Lane KB. Pleural space as a site of ectopic gene delivery: Transfection of pleural mesothelial cells with systemic distribution of gene product. Chest 2003; 123: 202-8.
56. Murphy JE, Rheinwald JG. Intraperitoneal injection of genetically modified, human mesothelial cells for systemic gene therapy. Hum Gene Ther 1997; 8: 1867-79.
57. Chung-Welch N, Patton WF, Shepro D, Cambria RP. Human omental microvascular endothelial and mesothelial cells: Characterization of two distinct mesodermally derived epithelial cells. Microvasc Res 1997; 54: 108-20.
58. Foussat A, Balabanian K, Amara A, et al. Production of stromal cell-derived factor 1 by mesothelial cells and effects of this chemokine on peritoneal B lymphocytes. Eur J Immunol 2001; 31: 350-9.
59. Mandl-Weber S, Cohen CD, Haslinger B, Kretzler M, Sitter T. Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cells. Kidney Int 2002; 61: 570-8.
60. Cronauer MV, Stadlmann S, Klocker H, et al. Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: Induction by interleukin-1. Am J Pathol 1999; 155: 1977-84.
61. Offner FA, Feichtinger H, Stadlmann S, et al. Transforming growth factor-beta synthesis by human peritoneal mesothelial cells. Induction by interleukin-1. Am J Pathol 1996; 148: 1679-88.
62. Gary Lee YC, Melkerneker D, Thompson PJ, Light RW, Lane KB. Transforming growth factor beta induces vascular endothelial growth factor elaboration from pleural mesothelial cells in vivo and in vitro. Am J Respir Crit Care Med 2002; 165: 88-94.
63. Kimura I, Sakamoto Y, Shibasaki M, Kobayashi Y, Matsuo H. Release of endothelins and platelet-activating factor by a rat pleural mesothelial cell line. Eur Respir J 2000; 15: 170-6.
64. Lee TC, Zhang Y, Aston C, et al. Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules. Cancer Res 1993; 53: 2858-64.
65. Warn R, Harvey P, Warn A, et al. HGF/SF induces mesothelial cell migration and proliferation by autocrine and paracrine pathways. Exp Cell Res 2001; 267: 258-66.
66. Adamson IY, Bakowska J, Prieditis H. Proliferation of rat pleural mesothelial cells in response to hepatocyte and keratinocyte growth factors. Am J Respir Cell Mol Biol 2000; 23: 345-9.
67. Faull RJ, Stanley JM, Fraser S, Power DA, Leavesley DI. HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration. Kidney Int 2001; 59: 614-24.
68. Kuwahara M, Kagan E. The mesothelial cell and its role in asbestos-induced pleural injury. Int J Exp Pathol 1995; 76: 163-70.
69. Simsir A, Fetsch P, Mehta D, Zakowski M, Abati A. E-cadherin, N-cadherin, and calretinin in pleural effusions: The good, the bad, the worthless. Diagn Cytopathol 1999; 20: 125-30.
70. Damas JK, Waehre T, Yndestad A, et al. Stromal cell-derived factor-1alpha in unstable angina: Potential antiinflammatory and matrix-stabilizing effects. Circulation 2002; 106: 36-42.
71. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37: 1563-70.
72. Baer AN, Green FA. Cyclooxygenase activity of cultured human mesothelial cells. Prostaglandins 1993; 46: 37-49.
73. Bourbon JR, Chailley-Heu B. Surfactant proteins in the digestive tract, mesentery, and other organs: Evolutionary significance. Comp Biochem Physiol A Mol Integr Physiol 2001; 129: 151-61.
74. Cicila GT, O'Connell TM, Hahn WC, Rheinwald JG. Cloned cDNA sequence for the human mesothelial protein 'mesosecrin' discloses its identity as a plasminogen activator inhibitor (PAI-1) and a recent evolutionary change in transcript processing. J Cell Sci 1989; 94 (Pt 1): 1-10.
75. Askari AT, Unzek S, Popovic ZB, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003; 362: 697-703.
76. Bourahla B, Meilhac O, Michel JB, Elmadbouh I, Carpentier A, Chachques JC. Mesothehial cells for myocardial regeneration: Revival of the omentum. Circulation 2006; 114 (suppl II): II 412.